ReviewCancers2026
Digital 3D Technology in Pediatric Surgical Oncology: An Expert White Paper.
Review in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Digital three-dimensional (3D) visualization is an evolving field that is being introduced into pediatric surgical oncology, where it addresses challenges related to complex anatomy and difficulties accurately defining surgical margins. This paper provides an overview of digital 3D modeling in pediatric surgical oncology and explores ways to further advance this field. Digital 3D models may improve various aspects of surgery, such as preoperative planning, intraoperative guidance, patient education, and surgical training. Traditionally, 3D models are manually or semi-automatically segmented. More recently, artificial intelligence (AI) can automatically segment pediatric solid tumors. For preoperative planning, 3D models improve anatomic understanding and help multidisciplinary communication. During surgery, these models can assist the surgeon in accurately localizing tumors and determining resection margins in preclinical research settings. In patient education, 3D models present an opportunity to improve patient understanding of disease, therapy, and surgical risks. Lastly, digital 3D models are used in surgical training, particularly for challenging cases. Although digital 3D technologies are evaluated using technical performance metrics, these measures do not necessarily result in improved clinical outcomes. Consequently, evidence demonstrating improved surgical outcomes remains limited, also due to the small patient cohorts. Several challenges continue to hinder clinical translation, including image quality and standardization, segmentation complexity, organ deformability during surgery, and insufficient clinical validation. Addressing these limitations will require progress in four key areas: AI integration, multicenter validation, the development of centralized infrastructures including digital twins, and scalable implementation strategies that support widespread clinical adoption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.